Matthew Greenblatt
Clinical Pathology/Laboratory Medicine · New York, NYNPI 1043653405
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $13,998 of the $19,240 with a category attached, or 72.8%. Amgen accounts for 81.1% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $12,415, more than ten times the $550 reported in 2019.
Across 17 payments — averaging $1131.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$16K
- BD$2K
- Musculoskeletal Transplant Foundation Inc.$1K
- Illumina, Inc.$420
- Biofire Diagnostics, LLC$325
- Stryker$271
What the payments were for
- Consulting fees$4,70924%
- Speaking & faculty fees$13,99873%
- Food & beverage$5333%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 4 | $15,601 |
| BD | 3 | $1,523 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $1,100 |
| Illumina, Inc. | 1 | $420 |
| Biofire Diagnostics, LLC | 1 | $325 |
| Stryker | 6 | $271 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVENITY$14,008
- Prolia$1,593
- Oncology Testing$420
- BioFire FilmArray$325
- CITREFIX$137
How this compares
$19,240 in reported general payments places this provider in the 85th percentile of 37 clinical pathology/laboratory medicine providers in New York.
See all clinical pathology/laboratory medicine providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical pathology/laboratory medicine in New York
- Anjali SaqiNew York$182K
- Melissa CushingNew York$139K
- Ahmet DoganNew York$25K
- Alexander KratzNew York$3K
- Daniel GreenNew York$3K
- Ila SinghNew York$2K
- Tobias CohenNew York$266
- Anthony CardilloNew York$135
- Elena MaryamchikNew York$97
- Amanda BlouinNew York$45
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.